Literature DB >> 20579098

The immune system vs. Pseudomonas aeruginosa biofilms.

Peter Østrup Jensen1, Michael Givskov, Thomas Bjarnsholt, Claus Moser.   

Abstract

Ilya Metchnikoff and Paul Ehrlich were awarded the Nobel price in 1908. Since then, numerous studies have unraveled a multitude of mechanistically different immune responses to intruding microorganisms. However, in the vast majority of these studies, the underlying infectious agents have appeared in the planktonic state. Accordingly, much less is known about the immune responses to the presence of biofilm-based infections (which is probably also due to the relatively short period of time in which the immune response to biofilms has been studied). Nevertheless, more recent in vivo and in vitro studies have revealed both innate as well as adaptive immune responses to biofilms. On the other hand, measures launched by biofilm bacteria to achieve protection against the various immune responses have also been demonstrated. Whether particular immune responses to biofilm infections exist remains to be firmly established. However, because biofilm infections are often persistent (or chronic), an odd situation appears with the simultaneous activation of both arms of the host immune response, neither of which can eliminate the biofilm pathogen, but instead, in synergy, causes collateral tissue damage. Although the present review on the immune system vs. biofilm bacteria is focused on Pseudomonas aeruginosa (mainly because this is the most thoroughly studied), many of the same mechanisms are also seen with biofilm infections generated by other microorganisms.

Entities:  

Mesh:

Year:  2010        PMID: 20579098     DOI: 10.1111/j.1574-695X.2010.00706.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  83 in total

Review 1.  Sensing the unreachable: challenges and opportunities in biofilm detection.

Authors:  Yikang Xu; Yousr Dhaouadi; Paul Stoodley; Dacheng Ren
Journal:  Curr Opin Biotechnol       Date:  2019-11-22       Impact factor: 9.740

Review 2.  Applying insights from biofilm biology to drug development - can a new approach be developed?

Authors:  Thomas Bjarnsholt; Oana Ciofu; Søren Molin; Michael Givskov; Niels Høiby
Journal:  Nat Rev Drug Discov       Date:  2013-10       Impact factor: 84.694

3.  Antipseudomonal agents exhibit differential pharmacodynamic interactions with human polymorphonuclear leukocytes against established biofilms of Pseudomonas aeruginosa.

Authors:  Athanasios Chatzimoschou; Maria Simitsopoulou; Charalampos Antachopoulos; Thomas J Walsh; Emmanuel Roilides
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

4.  Incorporation of phosphorylcholine into the lipooligosaccharide of nontypeable Haemophilus influenzae does not correlate with the level of biofilm formation in vitro.

Authors:  Carmen Puig; Sara Marti; Peter W M Hermans; Marien I de Jonge; Carmen Ardanuy; Josefina Liñares; Jeroen D Langereis
Journal:  Infect Immun       Date:  2014-01-22       Impact factor: 3.441

5.  Identification of a novel benzimidazole that inhibits bacterial biofilm formation in a broad-spectrum manner.

Authors:  Karthik Sambanthamoorthy; Ankush A Gokhale; Weiwei Lao; Vijay Parashar; Matthew B Neiditch; Martin F Semmelhack; Ilsoon Lee; Christopher M Waters
Journal:  Antimicrob Agents Chemother       Date:  2011-06-27       Impact factor: 5.191

Review 6.  Recent developments for Pseudomonas vaccines.

Authors:  Anurag Sharma; Anja Krause; Stefan Worgall
Journal:  Hum Vaccin       Date:  2011-10-01

7.  Antibiotic-loaded synthetic calcium sulfate beads for prevention of bacterial colonization and biofilm formation in periprosthetic infections.

Authors:  R P Howlin; M J Brayford; J S Webb; J J Cooper; S S Aiken; P Stoodley
Journal:  Antimicrob Agents Chemother       Date:  2014-10-13       Impact factor: 5.191

8.  Bead-size directed distribution of Pseudomonas aeruginosa results in distinct inflammatory response in a mouse model of chronic lung infection.

Authors:  L J Christophersen; H Trøstrup; D S Malling Damlund; T Bjarnsholt; K Thomsen; P Ø Jensen; H P Hougen; N Høiby; C Moser
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

9.  Rapid diversification of Pseudomonas aeruginosa in cystic fibrosis lung-like conditions.

Authors:  Alana Schick; Rees Kassen
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-01       Impact factor: 11.205

Review 10.  Pseudomonas aeruginosa biofilms in disease.

Authors:  Lawrence R Mulcahy; Vincent M Isabella; Kim Lewis
Journal:  Microb Ecol       Date:  2013-10-06       Impact factor: 4.552

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.